NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
08 October 2024
| Name: | BOTANIX PHARMACEUTICALS LTD (BOT) | |||||||||||||||
| ISIN: | AU000000BOT2 | |||||||||||||||
| Date of Listing: | 24 January 1985 | |||||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 009 109 755ABN: 70 009 109 755
Registration Date: 21 September 1984
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| BOTANIX PHARMACEUTICALS LTD | 07/07/2016 | |
| BONE MEDICAL LIMITED | 20/08/2004 | 07/07/2016 |
| REVENIR LIMITED | 22/01/2004 | 20/08/2004 |
| ALIQUOT ASSET MANAGEMENT LIMITED | 20/08/2001 | 22/01/2004 |
| AERODATA HOLDINGS LIMITED | 20/08/2001 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
The securities of Botanix Pharmaceuticals Ltd will be reinstated to official quotation immediately following the release of an announcement regarding a capital raising. | 05/04/2017 |
The company releases a capital raising presentation. | 05/04/2017 |
The company has received commitments to raise A$7.4 million via a significantly oversubscribed placement to existing and new institutional and sophisticated investors. | 05/04/2017 |
The securities of Botanix Pharmaceuticals Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. | 04/04/2017 |
Botanix Pharmaceuticals Limited (formerly Bone Medical Limited; "the Company") will be reinstated to official quotation as from the commencement of trading on Friday 15 July 2016, following the Company's recompliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. | 13/07/2016 |
name changed from Bone Medical Limited | 07/07/2016 |
The securities of Botanix Pharmaceuticals Ltd will be reinstated to official quotation immediately following the release of an announcement regarding a capital raising. | 05/04/2017 |
The company releases a capital raising presentation. | 05/04/2017 |
The company has received commitments to raise A$7.4 million via a significantly oversubscribed placement to existing and new institutional and sophisticated investors. | 05/04/2017 |
The securities of Botanix Pharmaceuticals Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. | 04/04/2017 |
Botanix Pharmaceuticals Limited (formerly Bone Medical Limited; "the Company") will be reinstated to official quotation as from the commencement of trading on Friday 15 July 2016, following the Company's recompliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. | 13/07/2016 |
name changed from Bone Medical Limited | 07/07/2016 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 25/10/2016 | Graham Griffiths | 1,000,000 | $0.049 | $49,395 |
| 10/04/2015 | Robert Towner | -2,500,000 | $0.013 | $32,440 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Vince Ippolito | Executive Chairman | 20/05/2019 |
| Howie McKibbon | CEO | 24/08/2023 |
| Graeme Morissey | CFO | 26/03/2024 |
| Daniel Sharp | Non Exec Director | 22/03/2022 |
| Stewart Washer | Non Exec Director | 21/02/2019 |
| Matt Callahan | Executive Director | 01/07/2016 |
| William Bosch | Executive Director | 01/07/2016 |
| Susan Park | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Michael Thurn | Executive Director, COO | 14/02/2017 | 26/02/2021 |
| Ric Peterson | CFO | 01/08/2019 | 31/05/2020 |
| Robert Towner | Non Exec Chairman | 28/01/2014 | 11/02/2020 |
| Graham Griffiths | Non Exec Chairman | 01/07/2016 | 08/02/2019 |
| John Hannaford | Non Exec Director | 28/01/2014 | 01/07/2016 |
| Phillip Wingate | Non Exec Director | 27/11/2014 | 01/07/2016 |
| Roger New | Non Exec Director | 02/06/2005 | 27/11/2014 |
| Peter Young | Managing Director, CEO | 05/04/2011 | 12/05/2014 |
| Leon Ivory | Director | 16/11/2005 | 24/01/2014 |
| Peter Brooks | Director | 25/07/2007 | 24/01/2014 |
| Barry Walker | Non Exec Director | 16/11/2005 | 19/08/2011 |
| Leif Jensen | Non Exec Chairman | 27/05/2008 | 01/08/2011 |
| Troels Jordansen | Managing Director | 16/11/2006 | 02/06/2009 |
| Paul Hopper | Executive Chairman | 02/07/2005 | 16/07/2007 |
| Richard Basham | Non Exec Director | 18/05/2004 | 11/04/2006 |
| Christopher Bilkey | Non Exec Director | 02/08/2004 | 16/11/2005 |
| Wayne Fritzsche | Non Exec Director | 11/04/2005 | 14/11/2005 |
| Micahel Redman | CEO | 28/02/2005 | 07/11/2005 |
| Glen Travers | Non Exec Director | 02/08/2004 | 03/06/2005 |
| Michael Perrott | Non Exec Chairman | 31/05/2001 | 30/05/2005 |
| James Phillips | CEO | 12/08/2004 | 28/02/2005 |
| Terence Kestel | Non Exec Director | 16/12/2003 | 30/11/2004 |
| Peter Huston | Non Exec Director | 29/11/2000 | 12/05/2004 |
| Antony Rigoll | Executive Director | 29/11/2000 | 16/12/2003 |
| Andrew Brown | Non Exec Director | 19/02/2003 | 28/11/2003 |
| Bruce Burrell | Non Exec Director | 19/02/2003 | 28/11/2003 |
| Paul Crowther | Non Exec Director | 19/02/2003 | 04/04/2003 |
| David Argyle | Non Exec Director | 30/04/2001 | 31/07/2002 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
